In this research, a haptacyclic carbazole-based dithienocyclopentacarbazole (DTCC) ladder-type structure was formylated to couple with two 1,1-dicyanomethylene-3-indanone (IC) moieties, forming a new nonfullerene acceptor DTCCIC-C17 using a bulky branched 1-octylnonayl side chain at the nitrogen of the embedded carbazole and four 4-octylphenyl groups at the sp 3 -carbon bridges. The rigid and coplanar main-chain backbone of the DTCC core provides a broad light-absorbing window and a higher-lying LUMO energy level, whereas the bulky flanked side chains reduce intermolecular interactions, making DTCCIC-C17 amorphous with excellent solution processability. The DTCCIC-C17 as an acceptor is combined with a medium band gap polymer poly[(2,6-(4,8-bis(5-(2-ethylhexyl)thiophen-2-yl)-benzo[1,2- b:4,5- b ′]dithiophene))- alt -(5,5-(1′,3′-di-2-thienyl-5′,7′-bis(2-ethylhexyl)benzo[1′,2′- c:4′,5′- c ′]dithiophene-4,8-dione))] (PBDB-T) as the donor in the active layer to obtain suitable highest occupied molecular orbital/lowest unoccupied molecular orbital energy alignments and complimentary absorption. The devices with an inverted configuration (ITO/ZnO/active layer/MoO 3 /Ag) without using an aqueous poly(3,4-ethylenedioxythiophene) polystyrene sulfonate layer were fabricated for better device stability. When the diiodooctane-treated PBDB-T:DTCCIC-C17 active layer was thermally annealed at 50 °C for 10 min, the device achieved the highest efficiency of 9.48% with a high V oc of 0.98 V, a J sc of 14.27 mA cm –2, and an FF of 0.68.
No takes yet. Share an insight, caveat, or question.
Hsiao et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: